Search
for

    Did you mean Skindex-16?
    Glossary Skindex-16

    dermatology questionnaire assessing skin condition impact on quality of life

    Skindex-16 is a dermatology-specific questionnaire designed to measure the impact of skin conditions on a patient's quality of life. It consists of 16 questions that assess symptoms, emotions, and functioning, providing valuable insights for both patients and healthcare professionals to evaluate the psychological and social effects of skin diseases like alopecia.

    Related Terms

    Research 10 of 210

    1. PCR30 PSYCHOMETRIC EVALUATION OF SKINDEX-16 AA, THE ALOPECIA AREATA SYMPTOM IMPACT SCALE (AASIS), AND THE SCALP HAIR ASSESSMENT PATIENT-REPORTED OUTCOME (PRO) IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    2. Assessing a measure for Quality of Life in patients with severe Alopecia Areata: a multicentric Italian study Frontiers in Public Health · 2024
    3. 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries Journal of the American Academy of Dermatology · 2025
    4. Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials JEADV Clinical Practice · 2023
    5. Quality of life in patients with alopecia areata: a hospital‐based cross‐sectional study Journal of the European Academy of Dermatology and Venereology · 2015 · 25 citations
    6. Psychosocial and mental impact of alopecia areata: Analysis of the Danish Skin Cohort Journal of the European Academy of Dermatology and Venereology · 2024 · 17 citations
    7. Treatment Patterns and Health-Related Quality of Life in Patients with Alopecia Areata Stratified by Disease Severity in the USA Dermatology and Therapy · 2026
    8. The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata Dermatology and Therapy · 2023 · 40 citations
    9. Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA) SKIN The Journal of Cutaneous Medicine · 2025
    10. Treatment of Alopecia Areata with Oral JAK Inhibitor : Focusing on Clinical Outcomes with Baricitinib The Nishinihon Journal of Dermatology · 2022 · 1 citations
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →